KD Logo

Secretary, Treasurer & CFO STEPHENSON BRIAN C sold 4,148 shares of BridgeBio Pharma Inc [BBIO]

The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. BridgeBio Pharma Inc shares valued at $149,973 were sold by STEPHENSON BRIAN C on Feb 19 ’25. At $36.16 per share, STEPHENSON BRIAN C sold 4,148 shares. The insider’s holdings dropped to 102,464 shares worth approximately $3.77 million following the completion of this transaction.

Also, Kumar Neil sold 31,543 shares, netting a total of over 1,140,024 in proceeds. Following the sale of shares at $36.14 each, the insider now holds 211,718 shares.

Before that, NEIL KUMAR had added 31,543 shares to its account. In a trade valued at $1,119,461, the Director bought BridgeBio Pharma Inc shares for $35.49 each.

As published in their initiating research note from Scotiabank on October 16, 2024, BridgeBio Pharma Inc [BBIO] has been a Sector outperform. Analysts at Oppenheimer started covering the stock with ‘”a Perform”‘ outlook in a report released in early October. As of September 04, 2024, Piper Sandler has initiated its “an Overweight” rating for BBIO.

Analyzing BBIO Stock Performance

During the last five days, there has been a surge of approximately 15.20%. Over the course of the year, BridgeBio Pharma Inc shares have jumped approximately 34.13%. Shares of the company reached a 52-week high of $39.47 on 02/20/25 and a 52-week low of $27.53 on 01/02/25. A 50-day SMA is recorded $31.51, while a 200-day SMA reached $27.60. Nevertheless, trading volume fell to 7.25 million shares from 4.17 million shares the previous day.

Support And Resistance Levels for BridgeBio Pharma Inc (BBIO)

According to the 24-hour chart, there is a support level at 34.95, which, if violated, would cause prices to drop to 33.10. In the upper region, resistance lies at 39.06. The next price resistance is at 41.32. RSI (Relative Strength Index) is 63.65 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at 2.90, which suggests the price will increase in the coming days. Percent R is at 29.71%, indicating bullish price movement. Stochastics %K at holding indicates that the stock is to be held.

Most Popular